Othram Inc., founded in 2018 and headquartered in the United States, is transforming the landscape of forensic investigations. The company seamlessly integrates laboratory science, innovative software, and processes to tackle both cold and contemporary cases. With its proprietary technology, Othram enables law enforcement agencies globally to solve cases previously considered unsolvable, establishing itself as a leader in forensic DNA analysis.
Othram uniquely manages all casework in-house, ensuring a streamlined process and adherence to high-quality standards. The company's forensic laboratory is accredited by the ANSI National Accreditation Board to ISO/IEC 17025:2017 for Forensic Testing and Calibration, utilizing advanced Single-Nucleotide Polymorphism (SNP) testing.
Recently, Othram Inc. received a $6.56M late-stage venture capital investment on 01 February 2024, highlighting investor confidence in its mission-driven, innovative approach to forensic investigations.